Bowel screening kit with extras could help save more lives
Thousands more people would take part in bowel cancer screening if the kit included extras, such as gloves and “poo catchers”, according to a Cancer Research UK study published today in Biomed Research International*.
"We encourage people to complete the test and post their kits back - it may be easier than you think and it really could save your life." - Sara Hiom, Cancer Research UK
The London study looked at how to increase the number of people who take part in the NHS Bowel Cancer Screening Programme (BCSP)**, with fewer than six in ten 60 to 74 year olds in England returning the kit.
It found that more people took part when they were also sent special latex-free gloves and “poo catchers”, and a recommendation from Cancer Research UK that people take part, alongside a local advertising campaign that included posters at bus stops and TV ads in GP surgeries.
Bowel cancer screening*** uptake rose from around 43 to 50 per cent among 60-69 year olds and from 47 to 54 per cent among 70-74 year olds.
This still falls short of the target of 60 per cent uptake, and the 75 percent ambition recently announced in the independent taskforce’s cancer strategy for England.
But it means, if all the extras were run together for a whole year, nearly 26,000 extra people could take up screening in London alone.****
It is estimated that the NHS bowel cancer screening programme could save 1,800 to 2,400 lives each year in England by 2025.
The pilot study was conducted by Cancer Research UK, along with support from NHS England (London region), Public Health England, the Department of Health, and the English NHS Bowel Cancer Screening Programme.
Becky White, lead author and senior analyst at Cancer Research UK, said: “Some people are hesitant to do the test. Some find taking and storing samples unpleasant; others have difficulty completing the test and some misunderstand the instructions. But our findings are encouraging and have shown ways to overcome these barriers by offering practical improvements.”
Sara Hiom, Cancer Research UK’s director of early diagnosis, said: “The chances of surviving bowel cancer are much greater when it’s caught at an early stage. And screening is a crucial way to catch the disease early, before symptoms develop. Making the test easier for people, raising awareness, identifying why certain people don’t take the test and working out what can be done to address barriers, are all vital if we are to encourage more people to want to take part.
“We do understand that the NHS needs extra investment as they are already overstretched. But earlier diagnosis and earlier treatment are key to reducing the future burden of high treatment costs for the NHS.
“We encourage people to complete the test and post their kits back – it may be easier than you think and it really could save your life.”
For media enquiries contact the Cancer Research UK press office on 020 3469 8300 or, out of hours, on 07050 264 059.
Notes to Editor
** The gFOBT Bowel Cancer Screening Programme (BCSP) sends all eligible men and women an invitation to participate in bowel screening that includes an information leaflet about bowel cancer and the screening process. One to two weeks later, a letter containing the kit, cardboard gFOBT sticks, instructions for completing the kits, and a prepaid return envelope are sent.
Invitees are instructed to collect two small faecal samples each from three separate bowel motions, to spread onto six different windows on the kit.
*** gFOBT is the guaiac faecal occult blood test. Uptake in the campaign pilot evaluation was calculated out of those sent kits, and is not directly comparable to NHS Bowel Cancer Screening Programme uptake statistics, which are calculated out of all of those invited.
****404,338 people were invited to the Bowel Cancer Screening Programme in the London Screening Hub in 2012-13 (source: http://www.publications.parliament.uk/pa/cm201314/cmhansrd/cm140401/text/140401w0001.htm#1404026000191). Based on the campaign pilot evaluation, it was estimated that 98.4% of these would be sent kits (397,869 people). The modelled increase in uptake when all three interventions were piloted together (compared to controls) was applied to the expected number of people sent kits in London, to estimate the potential number of additional people screened if the three interventions ran together for a year. These estimates assume that two thirds of the people invited were 60-69 years old, and a third were 70-74.